Barclays PLCLSE: BARC

Barclays: Form8.3ADVANCEDMEDICALSOLUTIONSGROUPPL Replacement

· Issued by Barclays PLC via RNS

Summary by 6ix AI

Barclays PLC filed an amended Form 8.3, a UK Takeover Code disclosure by holders of 1% or more of a company's shares, on its position and dealings in ADVANCED MEDICAL SOLUTIONS GROUP PLC 5p ordinary shares on October 14, 2026. It replaces RNS number 1859Z, published at 15:11 on October 15, 2026, with changes to sections 2A (positions) and 3B (cash-settled derivative dealings).

Key details

  • Interests totalled 8,514,832 shares (3.85% of the 5p ordinary shares): 7,507,448 (3.40%) owned or controlled and 1,007,384 (0.46%) through cash-settled derivatives, contracts settled in cash rather than shares.
  • Short positions, which gain if the share price falls, totalled 8,516,938 (3.86%): 1,009,504 (0.46%) owned or controlled and 7,507,434 (3.40%) through cash-settled derivatives.
  • Barclays made four purchases of 1,295 to 35,799 shares at 2.8200 GBP to 2.8250 GBP, and three sales of 5,270 to 16,220 shares at 2.8200 GBP to 2.8254 GBP.
  • It also dealt in swaps and contracts for difference, which are cash-settled derivatives, opening or increasing short positions and decreasing or closing long positions, at 2.8200 GBP to 2.8252 GBP.
  • Barclays reported no indemnity or option arrangements that may be an inducement to deal, and no agreements relating to voting rights under options or of securities referenced by derivatives, and said it is not making disclosures for any other party to the offer.

6ix AI wrote this summary from the release below and checked it against the release.

Barclays PLC
30 October 2026
 

FORM 8.3 Amendment - this form replaces RNS number 1859Z  published at 15:11 on 15/10/2026 , changes made to section 2A,3B

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

relevant securities this form relates:

ADVANCED MEDICAL SOLUTIONS GROUP PLC

(d)

If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e)

Date position held/dealing undertaken:

14 Oct 2026

(f)

In addition to the company in 1(c) above, is the discloser making

disclosures in respect of any other party to the offer?

NO

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

to which the disclosure relates following the dealing(if any)

Class of relevant security:

5p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1) Relevant securities owned and/or controlled:

7,507,448

3.40%

1,009,504

0.46%

(2) Cash-settled derivatives:

1,007,384

0.46%

7,507,434

3.40%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 

0

0.00%

0

0.00%

 

TOTAL:

8,514,832

3.85%

8,516,938

3.86%

(b)

Rights to subscribe for new securities (including directors and

other executive options)

Class of relevant security in relation to

which subscription right exists

Details, including nature of the rights

concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchase and sales

Class of relevant

security

Purchase/sale

Number of

securities

Price per unit

5p ordinary

Purchase

35,799

2.8250  GBP

5p ordinary

Purchase

5,270

2.8200  GBP

5p ordinary

Purchase

2,946

2.8249  GBP

5p ordinary

Purchase

1,295

2.8225  GBP

5p ordinary

Sale

16,220

2.8250  GBP

5p ordinary

Sale

8,982

2.8254  GBP

5p ordinary

Sale

5,270

2.8200  GBP

(b)

Cash-settled derivative transactions

Class of

relevant

security

Product  description

Nature of dealing

Number of

reference

securities

Price per

unit

5p ordinary

SWAP

Increasing Short

110

2.8250  GBP

5p ordinary

CFD

Decreasing Long

2,709

2.8252  GBP

5p ordinary

SWAP

Decreasing Long

2,544

2.8245  GBP

5p ordinary

SWAP

Opening Short

1,205

2.8245  GBP

5p ordinary

SWAP

Closing Long

54

2.8246  GBP

5p ordinary

SWAP

Closing Long

24

2.8200  GBP

5p ordinary

SWAP

Opening Short

4,807

2.8200  GBP

5p ordinary

SWAP

Increasing Short

3,306

2.8200  GBP

5p ordinary

SWAP

Increasing Short

79

2.8250  GBP

(c)

Stock-settled derivative transactions

(including options)

(i)

Writing, selling, purchasing or varying

Class

of

relevant

security

Product

description

Writing,

purchasing,

selling,

varying etc

Number

of

securities

to which

option

relates

Exercise

price

per unit

Type

Expiry

date

Option

money

paid/

received

per unit

(ii)

Exercise

Class of relevant

security

Product description

Exercising/ exercised against

Number of

securities

Exercise price per

unit

(d)

Other dealings (including subscribing for

new securities)

Class of relevant

security

Nature of Dealings

Details

Price per unit (if

applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the person making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or

derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

30-Oct-26

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Barclays PLC on 6ix

Story so far

Earlier from Barclays

Later from Barclays

All Barclays news releases